- Christopher Starr, Raptor Pharma's (RPTP) CEO since 2006, will be retiring at year's end. COO Julie Anne Smith will replace him.
- Starr will remain on Raptor's board following his resignation as CEO, and will conitnue to "consult on Raptor development projects."
- Smith has been Raptor's COO since Sep. '12. Prior to joining Raptor, she was the sales chief for Enobia Pharma.
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Benzinga.com (Feb 23, 2015)
at Investor's Business Daily (Jan 6, 2015)
at Investor's Business Daily (Jan 5, 2015)
at Nasdaq.com (Dec 29, 2014)
at CNBC.com (Mar 13, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs